Inpatient Admissions and Re-Admissions in Medicare Beneficiaries Initiating Umeclidinium/Vilanterol or Tiotropium Therapy
Michael Bogart,1 Gary Yat-Hung Leung,2 Anissa Cyhaniuk,2 Kristi DiRocco3 1Customer Engagement, Value, Evidence and Outcomes (CEVEO) US Medical Affairs, GSK, Research Triangle Park, NC, USA; 2STATinMED Research, Dallas, TX, USA; 3US Medical Affairs, GSK, Collegeville, PA, USACorrespondence: Kristi Di...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2024-02-01
|
| Series: | International Journal of COPD |
| Subjects: | |
| Online Access: | https://www.dovepress.com/inpatient-admissions-and-re-admissions-in-medicare-beneficiaries-initi-peer-reviewed-fulltext-article-COPD |